Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
HCC1143 | Alvocidib | 0.01 | 0.9857 | 0.00348 |
HCC1143 | Alvocidib | 0.01 | 0.9239 | -0.00059 |
HCC1419 | Alvocidib | 0.00316227766017 | 0.7552 | -0.00148 |
T47D | Alvocidib | 0.001 | 0.9691 | -0.00392 |
HCC1143 | Alvocidib | 0.0316227766017 | 0.9336 | -0.00465 |
T47D | Alvocidib | 0.000316228 | 1.0430 | 0.00473 |
HCC1419 | Alvocidib | 0.01 | 0.8489 | -0.00479 |
T47D | Alvocidib | 0.000316228 | 1.0616 | -0.00486 |
HCC1143 | Alvocidib | 0.0316227766017 | 0.9376 | 0.00062 |
T47D | Alvocidib | 0.000316228 | 1.0487 | -0.00604 |
HCC1419 | Alvocidib | 0.1 | 0.4575 | 0.00719 |
T47D | Alvocidib | 0.031622777 | 0.7439 | -0.00513 |
HCC1143 | Alvocidib | 0.1 | 0.7787 | 0.01332 |
T47D | Alvocidib | 0.003162278 | 1.0160 | -0.00208 |
HCC1419 | Alvocidib | 1.0 | -0.2663 | 0.12568 |
T47D | Alvocidib | 0.003162278 | 1.0722 | 0.00334 |
HCC1143 | Alvocidib | 0.1 | 0.6375 | 0.01151 |
T47D | Alvocidib | 1.0 | -0.0994 | 0.04134 |
HCC1500 | Alvocidib | 0.0001 | 0.9937 | -0.19571 |
HCC1143 | Alvocidib | 0.316227766017 | 0.1413 | 0.05993 |
HCC1143 | Alvocidib | 1.0 | -0.2855 | 0.21049 |
T47D | Alvocidib | 0.003162278 | 1.0963 | -0.00392 |
T47D | Alvocidib | 0.01 | 0.7013 | 0.01703 |
MDA-MB-361 | Alvocidib | 0.0001 | 0.6054 | 0.04068 |
MDA-MB-361 | Alvocidib | 0.0001 | 1.1633 | -0.00762 |